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 ABSTRACT  
 Diabetes is a common cause of small vessel disease leading to stroke and vascular 
dementia. While the function and structure of large cerebral vessels can be easily studied, 
the brain’s microvasculature remains difficult to assess. Previous studies have 
demonstrated that structural changes in the retinal vessel architecture predict stroke risk, 
but these changes occur at late disease stages. Our goal was to examine whether retinal 
vascular status can predict cerebral small vessel dysfunction during early stages of 
diabetes. Retinal vasoreactivity and cerebral vascular function were measured in 78 
subjects (19 healthy controls, 22 subjects with prediabetics, and 37 with type-2 diabetics) 
using a new noninvasive retinal imaging device (Dynamic Vessel Analyzer) and 
transcranial Doppler studies, respectively. Cerebral blood vessel responsiveness worsened 
with disease progression of diabetes. Similarly, retinal vascular reactivity was 
significantly attenuated in subjects with prediabetics and diabetics compared to healthy 
controls. Subjects with prediabetics and diabetes with impaired cerebral vasoreactivity 
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explore the relationship between retinal and cerebral vascular function in diabetes. 
Impairment of venous retinal responsiveness may be one of the earliest markers of 
vascular dysfunction in diabetes possibly indicating subsequent risk of stroke and 









Diabetes is a frequent cause of retinal and cerebral vascular disease leading to blindness, 
stroke, and vascular dementia.
1
 The examination of retinal blood vessels yields important 
information about small vessel architecture and function. Retinal vascular dysfunction occurs 
early in diabetes
2,3 
and contributes to the pathogenesis of retinopathy.
4
 Microcirculatory 
dysfunction and alterations in vascular architecture also play an important role in the 
development of cerebral small vessel ischemic disease. Because the retinal and cerebral 
microcirculation share common embryogenic, anatomical, and physiological properties, such 
as autoregulation of blood flow, retinal vascular changes may reflect cerebrovascular 
pathophysiology. Thus, the study of retinal vascular function may provide important 
information about predisposition to cerebrovascular disease associated with diabetes.
5
 Retinal 
photography-based epidemiological studies demonstrate that structural alterations of retinal 
blood vessels are associated with increased risk for cardiovascular disease, as well as cortical 
and subcortical infarcts.
6-11
 As these structural changes occur during advanced disease stages 
of diabetes, they are not ideal risk markers to assess the efficacy of therapeutic interventions 
or to identify patients at early disease stages when treatment is most efficacious. In contrast, 
measures of endothelial dysfunction that are already present at very early disease stages and 
therefore potentially reversible could prove to be clinically more meaningful. 
Flickering light is a well-established metabolic stimulus for the retinal vasculature,
2,12
 which 
causes vasodilation and increased blood flow in healthy individuals.
13,14
 Similarly, standard 
hyperventilation/breath hold (HVBH) during measurement of blood flow in the middle 
cerebral artery (MCA) by transcranial Doppler studies (TCDs) can be used to assess cerebral 
autoregulation.
15









 but the relationship between an impaired retinal response, cerebral 
dysautoregulation, and stroke risk in diabetes has not been studied. 
 
 Research Design and Methods  
 Subjects  
 Seventy-eight subjects, age 21 years and older (35 men, 43 women) were enrolled. 
Based on American Diabetes Association guidelines, individuals were classified as to have 
type-2 diabetes based on physician diagnosis, an HbA1c of at least 6.5% (48 mmol/mol) and 
fasting plasma glucose of >126 mg/dL (7 mmol/L). Prediabetes was defined by an HbA1c of 
5.7-6.4% (39-46 mmol/mol) and fasting plasma glucose level of 100-125 mg/dL (5.6-6.9 
mmol/L).  
The study was approved by the Institutional Review Board and followed the Tenets of the 
Declaration of Helsinki. After signing informed consent, all subjects completed a medical 
history, physical examination, and ocular examination. Subjects were required to have a 
normal eye examination with corrected acuity 20/30 or better and intraocular pressures below 
21 mmHg. All subjects were free from eye diseases, morbid obesity (body mass index [BMI] 
> 40 kg/m
2
) and were not pregnant. All subjects were nonsmokers and controls had no history 
of hypertension. Diabetic subjects’ blood pressures had to be controlled by antihypertensive 
medications.  
Transcranial Doppler Studies 
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(2 MHz probe, Siemens Sequoia, USA). Mean flow velocity was measured at rest and 
following HVBH maneuver. Pulsatility (PI) and resistency (RI) indexes were obtained as 
indirect measures of peripheral downstream compliance. Cerebral autoregulation was 
assessed following standardized HVBH maneuver.
19,20
  
  Eye Studies  
Retinal vessel diameters within a region of interest, at one-half to one disc diameter from the 
optic disc were measured using a modified fundus camera (Zeiss FF450, Zeiss Jena, 
Germany). The diameters were combined into summary indices, including the central retinal 
arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE). From these 
equivalents, the summary index of all arteriolar and venular diameters was calculated and 
expressed as arteriole-to-venule ratio (AVR).  
 
To assess retinal vasomotor function, vessel diameter changes following flickering light 
stimulation compared to resting state were measured by the Dynamic Vessel Analyzer 
software (DVA, Imedos Inc, Germany) following our previously described protocol.
3
 The eye 
with the best visual acuity was dilated with tropicamide (1%) and, if needed, phenylephrine 
(2.5%).  
 Experimental Protocol  
An initial room air-breathing period was used to allow stabilization of baseline parameters. 
After a rest period of 15 minutes, flickering light measurements were conducted. The 
subject’s retinal vessels were imaged continuously as previously described.
2,3,18
 After 15 
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Blood pressure and heart rate were measured continuously by EKG and Finometer (model 
2300, Ohmeda, Boulder, CO, confirmed by an automated sphygmomanometer, Dinamap, 
Critikon, Tampa, FL) and collected online at 200 Hz for subsequent Medlab analysis. 
Additionally, end tidal CO2 and finger oxygen saturation were continuously measured during 
the HVBH maneuver using a respiratory gas monitor (RGM 5250; Ohmeda, Madison, WI) 
and pulse oximetry (Biox 3740, Ohmeda, Louisville, CO) to ensure sufficient change in 
blood gases. Fasting glucose, insulin, hemoglobin HbA1c, and lipid profile were measured 
using radioimmunoassays (Diagnostic Products Corp., Los Angeles, CA).  
 Data Analysis  
For flickering light trials, resting baseline measurements were averaged from the last 
15 seconds of resting conditions and peak retinal dilation was captured from the last 
3-10 seconds of the flickering stimuli and the first 3 seconds after the stimulus ended. 
The percentage change in vessel diameter was calculated comparing baseline retinal 
diameter as previously described.
3,18
 The overall range of change in the retinal 
diameter known as relative amplitude was calculated.
12
  
For the HVBH trials, the last 30 seconds of resting baseline and the first 5 seconds 
after breath hold were measured and the percent change from baseline was calculated. 
ANOVA testing was used to compare retinal vessel diameter changes and 
hemodynamic cerebral data between the three groups. Vasomotor responses following 
HVBH within each group were compared using paired t-tests. Merging data from all 
groups, correlations between retinal and cerebral vasoreactivity were assessed by 
Pearson’s correlation coefficients and adjusted for covariates (glucose and insulin) 
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adjust for age, blood pressure, and hyperlipidemia on measures of retinal and cerebral 
vasoreactivity and on the correlation between cerebral and retinal vasoreactivity.  
 
 Results  
 Group Characteristics  
Demographic details are summarized in Table 1. Seventy individuals completed all vascular 
studies (19 healthy controls, 21 with prediabetes, and 30 patients with diabetes). Most 
diabetic subjects received oral diabetic medications (87%), and 20% were on combination 
therapy with long and/or short acting insulin. The majority of diabetic patients were on 
antihypertensive (93%) and statin (60%) medications, indicating that they had metabolic 
syndrome. Across all groups, increased BMI was associated with higher hsCRP levels (P = 
.008), but hsCRP levels were not different between groups and were also not associated with 
fasting lipid levels. There were no significant differences in blood pressure values between 
groups.  
 Transcranial Doppler Results  
Resting mean flow velocities in the MCA were comparable between all groups. However, 
vasoreactivity was significantly impaired in diabetic patients compared to healthy individuals 
(P = .004) with a steady decrease of cerebral blood vessel responsiveness across the diabetic 
spectrum (see Fig 1). Individuals with prediabetes tended to have worse vasoreactivity than 
healthy controls, but better cerebral autoregulatory function than their diabetic counterparts. 
Similarly, poor cerebral vasoreactivity was associated with higher HbA1c and higher fasting 
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cerebral autoregulation also had higher pulsatility and resistancy indices (P = .01 and P = 
.006, respectively) than those with normal cerebral vasoreactivity, as well as significantly 
higher HbA1c (P < .001) and fasting glucose levels (P = .01). These findings remained 
statistical significant after adjustment for age, blood pressure, and BMI. 
 
 Retinal Vessel Characteristics  
Standard measures of structural retinal blood vessel integrity including AVR, CRVE, and 
CRAE were not significantly different between groups. In contrast, retinal vascular reactivity 
following flickering light stimulation was significantly attenuated in subjects with 
prediabetics and in diabetic patients compared to healthy controls (Fig 2). This impairment in 
vasoreactivity of both retinal arterioles and venules progressed with worsening glucose 
regulation, and was already present in the early diabetic state (prediabetic arteriolar vascular 
impairment, P = .05, and prediabetic venular impairment, P = .004). Retinal venous reactivity 
was more severely attenuated than the arteriolar response (see Fig 2). These observations 
remained robust after adjustment for potential confounders (age, hypertension, dyslipidemia, 
statin use, and BMI). Flickering light stimulation did not significantly change resting heart 
rate or blood pressure. Resting retinal artery and vein diameters were similar at baseline 
between the three groups.  
 Correlation between Cerebral and Retinal Vascular Function  
Measures of structural retinal vessel changes including AVR, CRVE, and CRAE were not 
correlated with retinal or cerebral vasoreactivity (results not shown). In contrast, subjects 
with prediabetes and diabetes with impaired cerebral vasoreactivity showed a significant 




This article is protected by copyright. All rights reserved. 
10 
 
arteriolar vasoreactivity (Fig 3). We also found inverse associations between RI, PI, and 
retinal vasoreactivity (see Fig 4). Individuals with high RI and PI had attenuated retinal 
venular (r = .3, P = .029 for RI, and P = .035 for PI) as well as arteriolar (r = .3, P = .02 
for RI, and P = .014, respectively) vasomotor responses. These observations also remained 
robust after adjustment for potential confounders (age, hypertension, dyslipidemia, statin use, 
and BMI).   
  
 Discussion  
We found an increase in cerebral arterial resistance across the diabetes spectrum, 
suggesting progression of cerebral microvascular disease as glucose regulation 
worsens. The decrease in vascular compliance was most pronounced in patients with 
poorly controlled diabetes and high HbA1c levels, but was already detectable in 
subjects with prediabetes. Although elevated RI and PI values are only indirect 
measures of small vessel disease with low specificity, these indices can be useful 
indicators of downstream vascular status.
19
 Increased flow indices in our study most 
likely suggest cerebral microangiopathy as subjects with aortic valve insufficiency or 
increased intracranial pressure were not included, and all subjects were free from 
significant intra- or extracranial stenosis. Furthermore, RI and PI remained 
significantly elevated across the diabetic spectrum after adjusting for age and blood 
pressure.   
Our findings of an impaired cerebral autoregulation in diabetes are consistent with 
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the absence of neurological dysfunction and stroke.
21,22
 Diabetes impairs endothelial 
function that can cause decreased cerebral perfusion, anaerobic metabolism of 
glucose, atherosclerosis,
23,24 
and subsequent stroke and dementia.
25
 The observation 
that impairment of cerebral vasoreactivity is already present in prediabetes, stresses 
the clinical importance of screening for prediabetes and tight glucose control in early 
disease stages when interventions are most effective to prevent vascular 
complications.  
Our findings of a worsening retinal vasoreactivity across the diabetic spectrum are 
consistent with previous observations.
2,17
 Our study suggests that impaired retinal 
venous reactivity is an earlier indicator of endothelial dysfunction in prediabetes and 
early stages of diabetes than retinal arterial dysfunction. This finding is in line with 
fundoscopy-based studies suggesting involvement of the retinal venous rather than the 
arterial microcirculation in early stages of diabetic retinopathy.
26,27
 Previous studies 
have described retinal venous stasis and enlargement of retinal veins as one of the 
earliest and sometimes only finding in diabetic retinopathy, found in about 10% to 
43% of patients with type 1 or type 2 diabetes.
28,29
 These venous changes can be 
associated with increased vascular permeability and impaired endothelial integrity of 
the microvasculature,
30




Epidemiological studies have shown that alterations in the architecture of retinal 
vessels are associated with higher risk of cardiovascular disease and stroke.
6-11
 Wider 
retinal vein diameters and decreased AVRs correlate with overall higher stroke risk, 









 These findings suggest that microvascular changes in the eye 
parallel the development of cerebrovascular disease, although further confirmatory 
studies are required. 
In contrast to previous studies, we did not find significant lower AVRs in our diabetic 
study population compared to controls. In addition, AVRs were surprisingly not 
associated with impaired retinal or cerebral vasoreactivity. This could be due to 
population bias, in that the present study enrolled primarily patients with earlier 
disease stages or individuals with better diabetes control, who do not yet show 
structural vessel alterations, but predominantly early endothelial dysfunction. It could 
also be due to the relatively small size of our study population as the overall effect 
size of reduced AVRs may be small in early stages of diabetes.  
We found a modest correlation between impaired retinal venous light flicker 
responses and alterations in cerebral autoregulation. This relatively modest 
association could also be due to the small size of the study population. However, it 
may also well be in line with previous observations, showing that large conduit 
vessels, such as the MCA, are differently affected by insulin resistance and diabetic 
metabolic dysfunction than the microcirculation.
35
 A linear relationship between 
hyperglycemia and diabetic microvascular complications has been described, whereas 
the effects of hyperglycemia on larger vessels remain less well understood. Several 
clinical trials seem to indicate that intense glucose control reduces the rate of 
microvascular, but not necessarily macrovascular complications,
35-38
 and that the 
efficacy of glucose control on vascular function in different vascular beds may also 
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The effects of diabetic metabolic dysfunction on vessels of different sizes may at least 
in part be explained by differences in vessel architecture and cellular constituents 
between the micro- and macrocirculation. In the retina, endothelial cells and pericytes 
are affected early by hyperglycemia-related oxidative stress, the production of 
advanced glycation end products, and epigenetic changes that cause endothelial 
dysfunction and inflammation that are followed by basal membrane thickening and 
small vessel drop out.
40
  
The impairment of vascular autoregulation may initially be more pronounced in 
smaller than large vessels, as it has been suggested that microvascular complications 
precede the onset of large vessel atherosclerotic disease, although this requires further 
study.
40
 The earlier impairment of the cerebral microvasculation may also explain 
why we found a stronger association between PI, RI, and impaired retinal venous and 
arteriolar responses to the flickering light stimulus.     
There are several limitations to the present study. First, the study involves the 
comparison of two different measures of vascular function (ie, blood velocity in the 
cerebral and diameter changes in the retinal vasculature). To control for this, we 
presented the data as percent change from baseline. Some of our subjects with 
diabetes (52%) required additional pupillary dilation by phenylephrine, which 
theoretically could elevate mean arterial pressure through increasing sympathetic 
stimulation; however, our findings did not change when these individuals were 
excluded from the analysis. A majority of the diabetic patients were taking statins, 
which could affect flow responses. However, the vasoconstrictor responses were still 
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results by statin use. In addition, associations remained robust when adjusting for 
blood pressure and age. Third, the sample size of this exploratory study was relatively 
small and future studies need to confirm associations between retinal vasoreactivity, 
cerebral dysautoregulation, and more importantly the risk of stroke and dementia. 
Conclusions 
Impairment of venous retinal responsiveness to flickering light is an early and 
sensitive marker of vascular complications in diabetes and could be easily detected by 
adding this measurement to routine eye examinations in clinical practice. Retinal and 
cerebral endothelial dysfunctions are already present in prediabetes and early stages 
of diabetes stressing the importance for early screening and intervention to prevent 
cerebrovascular disease.  
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Table1. Demographics: Population Characteristics of Study Cohorts  
 Healthy Prediabetics Diabetics P-Value 
Subjects 13 22 37  
Men/Women 7/12 10/12 18/19 .709 
Age (years) 52.47 ± 8.93 59.86 ± 9.86 57.57 ± 10.47 .44 
BMI 28.45 ± 5.03 29.03 ± 5.53 30.16 ± 5.01 .464 
HbA1c 5.279% ± .26 
(34 mmol/mol) 
6.04% ± .28 
(43 mmol/mol) 
7.47% ± 1.60 
(58 mmol/mol) 
.001 
hCRP 3.36 ± 4.72 3.13 ± 6.14 2.24 ± 2.60 .624 
Total cholesterol 199.58 ± 33.96 206.05 ± 34.16 174.27 ± 38.11 .003 
LDL 125.37 ± 8.03 128.27 ± 30.17 100.86 ± 33.93 .002 
HDL 55.42 ± 18.67 53.91 ± 15.55 44.97 ± 12.60 .022 
 Healthy controls, prediabetic, and diabetic patients were matched regarding age, 
gender, and BMI and had similar hCRP values. A majority of diabetics were on statin 
drugs and had significantly lower levels of total cholesterol and LDL, but also the lowest 
LDL levels compared to the other cohorts. BMI = body mass index; HbA1c = glycated 
hemoglobin; hCRP = high-sensitivity c-reactive protein; LDL = low-density lipoprotein; 
HDL = high-density lipoprotein.  
 
Fig 1. Cerebral vasoreactivity. Both subjects with prediabetes and type 2 diabetes showed an 
attenuated cerebral vasoreactivity of the middle cerebral artery following hyperventilation 
breath hold maneuver compared to controls (P = .04 for diabetics vs. controls; nonsignificant 
attenuation for prediabetics vs. controls and diabetics, respectively). After adjustment for age, 









Fig 2. Retinal vasoreactivity. Subjects with type 2 diabetes and prediabetes compared to 
healthy controls had attenuated retinal vasomotor responses (P = .003 for venous and P = 
.04 for arteriolar flicker response, respectively) across all groups. Patients with type 2 
diabetes exhibited a significantly attenuated arteriolar (P = .003) and venous (P = .012) 
vasodilation response to the flickering light stimulus compared to controls. Prediabetic 
subjects also exhibited significantly attenuated venous (.004), and to a lesser degree 
arteriolar (P = .52) vasodilation in response to the flickering light stimulus compared to 
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Fig 3. Relationship between cerebral and retinal vasoreactivity. Middle cerebral artery 
(MCA) reactivity following hyperventilation-breath hold maneuver versus retinal 
vasodilation response to flicker light stimulus across all groups. There was a significant 
modest correlation between reduced MCA reactivity and attenuated retinal venous 
vasodilation response to flicker light stimulus (r = .24, P = .046), but not retinal arterial 
vasodilation response (not shown). 
 
Fig 4. Correlation between retinal vasoreactivity and cerebral vascular compliance. Middle 
cerebral artery pulsatility index versus retinal vasodilation response to flicker light stimulus 
across groups. (A) There was a significant correlation between the venous retinal vasodilation 
response to flicker light stimulus and the pulsatility index (PI) (r = .33, P = .005). (B) There 
was also a significant correlation between retinal arteriolar vasodilation response to flicker 
light stimulus and the PI (r = .3, P = .011). Individuals with impaired retinal vasoreactivity 
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